Download the guide

This week's Fierce Biotech is brought to you by Sciensus Pharma Services.

Trouble viewing? Click here.
Sciensus
Integrating Clinical Studies with Patient Support Programs.
A holistic approach to rare disease care.
For rare disease patients, the opportunity to participate in clinical studies can be challenging, and for pharma firms, conducting observational studies can be an enormous undertaking.
In our latest expert guide, we explore the potential integration of clinical studies with patient support programs. A move which could enhance the depth and quality of your real-world data and give patients easier access to new life-changing treatments.
Integrating clinical studies and Patient Support Programs (PSPs) for holistic rare disease care.
Download the guide
Sciensus
linkedin

Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact aalcover@questex.com or call 202-824-5074.


You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor  
New York, NY 10017